P2.08-02 STAR-121: Phase 3 Study of DOM and ZIM plus Chemo vs Pembro plus Chemo in 1L mNSCLC with No Actionable Gene Alterations
Year: 2023
Type: article
Source: Journal of Thoracic Oncology
Authors: D. Rodriguez-Abreu, J. Bosch-Barrera, J.E. Gray, M.J. Ahn, M. Johnson, X. Yu, S. Mohammad, X. Chen, P. Phuong, J. Kim, M. Reck
Institutions: Hospital Universitario Insular de Gran Canaria, Institut Català d'Oncologia, Hospital Universitari de Girona Doctor Josep Trueta, Moffitt Cancer Center, Samsung Medical Center, Sarah Cannon, Gilead Sciences (United States), Arcus Biosciences (United States), German Center for Lung Research, LungenClinic Grosshansdorf
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4388045089